Intra-articular infliximab versus methylprednisolone in patients with knee osteoarthritis

Trial Profile

Intra-articular infliximab versus methylprednisolone in patients with knee osteoarthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jun 2012

At a glance

  • Drugs Infliximab (Primary) ; Methylprednisolone
  • Indications Osteoarthritis
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 30 Jun 2012 New trial record
    • 09 Jun 2012 Results presented at the 13th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top